Role of the phosphatidylinositol 3-kinase and mTOR pathways in the regulation of renal fibroblast function and differentiation
- 31 December 2007
- journal article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 39 (1) , 206-219
- https://doi.org/10.1016/j.biocel.2006.08.004
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Role of Mammalian Target of Rapamycin Signaling in Compensatory Renal HypertrophyJournal of the American Society of Nephrology, 2005
- LY294002 and rapamycin co‐operate to inhibit T‐cell proliferationBritish Journal of Pharmacology, 2005
- The mTOR/p70S6KSignal Transduction Pathway Plays a Role in Cardiac Hypertrophy and Influences Expression of Myosin Heavy Chain Genes in vivoCardiovascular Drugs and Therapy, 2004
- Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation1Transplantation, 2004
- Growth Factor-Stimulated Phosphorylation of Akt and p70S6K Is Differentially Inhibited by LY294002 and WortmanninEndocrinology, 2001
- p70s6k Integrates Phosphatidylinositol 3-Kinase and Rapamycin-Regulated Signals for E2F Regulation in T LymphocytesMolecular and Cellular Biology, 1999
- Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transductionNature, 1995
- Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation.Molecular and Cellular Biology, 1994
- Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin.Proceedings of the National Academy of Sciences, 1992
- Differentiation of primary and secondary fibroblasts in cell culture systemsMutation Research/DNAging, 1991